Morgan Stanley has upgraded Vir Biotechnology ( VIR, Financial) and uplifted its price target for the stock to $20 from ...

Wall Street giant Morgan Stanley promoted 173 of its employees to managing director roles this year, marking a 12% increase ...

Morgan Stanley (NYSE:MS) analysts have upgraded Vir Biotechnology (NASDAQ:VIR) to an "overweight" rating, shifting from "equal-weight," and have also increased their price target to $20 from $10. The ...

Morgan Stanley’s Asia wealth chief is looking to boost the number of staff dealing with its richest customers as the US ...

At Morgan Stanley, 2024 marked Ted Pick’s first full year at the helm of the firm and the restrained size of its new MDs ...

Jim Caron of Morgan Stanley Investment Management explains what's behind the steepening yield curve and what it's telling us ...

At Morgan Stanley, the new class is the first set of MD promotions under chief executive Ted Pick, who took the helm of the ...

Fintel reports that on January 8, 2025, Morgan Stanley upgraded their outlook for NetEase (OTCPK:NETTF) from Equal-Weight to ...

Morgan Stanleys Chief US Equity Strategist, Mike Wilson, forecasts a volatile first half of 2025, with recovery prospects ...

Morgan Stanley highlighted that the RBI has lifted restrictions on Asirvad Micro Finance with immediate effect. Morgan ...

In a report released today, Adam Jonas from Morgan Stanley maintained a Hold rating on Rivian Automotive (RIVN – Research Report), with a price ...

Brokerage expects NetEase's strong PC game pipeline to fuel an earnings turnaround, with forecasted revenue gains from games like Marvel Rivals and FragPunk. Additionally, the reintroduction of ...